Results

Total Results: 152 records

Showing results for "musculoskeletal".

101. Evidence Summary: Vitamin D Deficiency: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary18/vitamin-d-deficiency-screening
     November 25, 2014 - Comorbid conditions: Cardiovascular: 39% CNS or neurologic: 12% Psychiatric: <1% Musculoskeletal … Placebo 6 mo Psychosocial function ¶ Hypercalcemia; total AEs; and GI, respiratory, dermatologic, musculoskeletal

102. Archived: Evidence Summary: Vitamin D Deficiency: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary18/vitamin-d-deficiency-screening-november-2014
     November 25, 2014 - Comorbid conditions: Cardiovascular: 39% CNS or neurologic: 12% Psychiatric: <1% Musculoskeletal … Placebo 6 mo Psychosocial function ¶ Hypercalcemia; total AEs; and GI, respiratory, dermatologic, musculoskeletal

103. Evidence Summary: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/osteoporosis-screening
     January 14, 2025 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Osteoporosis to Prevent Fractures: Screening January 14, 2025 Recommendations made by the USPSTF are independent of the U.S. government. They should not be con…

104. Evidence Summary: Vitamin D Deficiency in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/vitamin-d-deficiency-screening
     April 13, 2021 - reported the following types of adverse events: abdominal discomfort, gastrointestinal issues, fatigue, musculoskeletal … Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer,

105. Evidence Summary: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing
     August 20, 2019 - medications were associated with undesirable adverse effects for some women, such as vasomotor and musculoskeletal … All medications were associated with symptomatic adverse effects, such as vasomotor and musculoskeletal

106. Evidence Summary: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - Symptomatic effects (eg, vasomotor, musculoskeletal) varied by medication. … All medications were associated with adverse effects, such as vasomotor or musculoskeletal symptoms,that

107. 75Ftpgw4Rz-3Tdmqpstvdg (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/75ftPGW4rZ-3tdMQPstvDg
     August 01, 2012 - interventions included increased fall-related outpatient visits after falls assessment, self-reported musculoskeletal

108. Recommendation: Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-adults-interventions
     September 18, 2018 - Three trials demonstrated mixed results for musculoskeletal problems.

109. Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/pskqLZMFcHjhtEF75uG4AP
     January 01, 2012 - Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement U.S. Preventive Services Task Force* Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation on screeni…

110. Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for CVD Prevention in Adults Without Known CVD Risk Factors: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/HMSNGkJatRuN5VoVWfbuFL
     March 01, 2022 - between intervention participants and control groups on any adverse events, serious ad- verse events, musculoskeletal

111. Screening for Osteoporosis to Prevent Fractures: A Systematic Evidence Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/-qaKjceN9BTy-oh7EFwXtk
     January 14, 2025 - Screening for Osteoporosis to Prevent Fractures: A Systematic Evidence Review for the US Preventive Services Task Force Screening for Osteoporosis to Prevent Fractures A Systematic Evidence Review for the US Preventive Services Task Force Leila C. Kahwati, MD, MPH; Christine E. Kistler, MD, MASc; Graham Booth, BSPH; …

112. Screening for Osteoporosis to Prevent Fractures: A Systematic Evidence Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/R_cAa3AjFGQ2np_aQnzQGA
     February 11, 2025 - Screening for Osteoporosis to Prevent Fractures: A Systematic Evidence Review for the USPSTF Screening for Osteoporosis to Prevent Fractures A Systematic Evidence Review for the US Preventive Services Task Force Leila C. Kahwati, MD, MPH; Christine E. Kistler, MD, MASc; Graham Booth, BSPH; Nila Sathe, MA, MLIS; Rache…

113. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
     April 15, 2013 - In STAR, raloxifene users reported more musculoskeletal problems, dyspareunia, and weight gain, whereas … serious adverse effects that impact quality of life and adherence, such as vasomotor, genital, and musculoskeletal

114. Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/-TsBkyewVoFpC7htRmzWJa
     September 03, 2019 - Symptomatic effects (eg, vasomotor, musculoskeletal) varied by medication. … All medications were associated with ad- verse effects, such as vasomotor or musculoskeletal symptoms

115. Draft Recommendation: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/osteoporosis-screening-prevent-fractures
     June 11, 2024 - Expert Panel on Musculoskeletal Imaging; Ward RJ, Roberts CC, Bencardino JT, et al.

116. Use of Medications to Reduce Risk for Primary Breast Cancer: A Systematic Review of the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/7ZSKduUYHWKe7q_tTY9xbF
     April 01, 2013 - In STAR, raloxifene users reported more musculoskeletal problems, dyspareunia, and weight gain, whereas … Volume 158 • Number 8 609 impact quality of life and adherence, such as vasomotor, genital, and musculoskeletal

117. Screening for Vitamin D Deficiency in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/XCAMvXugbjnYnGmeF5GtUS
     April 13, 2021 - reported the following types of adverse events: abdominal discomfort, gastrointestinal issues, fatigue, musculoskeletal … Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer,

118. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/MzHhsgTBL37rRvvJfkfgMZ
     August 20, 2019 - medications were associated with undesirable adverse effects for some women, such as vasomotor and musculoskeletal … All medications were associated with symptomatic adverse effects, such as vasomotor and musculoskeletal

119. Evidence Summary: Skin Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/skin-cancer-screening
     April 18, 2023 - Surveillance, Epidemiology, and End Results (SEER): Musculoskeletal System—Summary Staging Guide.

120. Evidence Summary: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening
     June 26, 2018 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Osteoporosis to Prevent Fractures: Screening June 26, 2018 Recommendations made by the USPSTF are independent of the U.S. government. They should not be con…